Showing results (171-180 of 906) with videos related to
Sort By:
Pageof 91
Hypertension (Dallas, Tex. : 1979)|August 19, 2009
Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertensionNathaniel Reichek, Richard B Devereux, Ricardo A Rocha, et al.Cardiovascular Drugs and Therapy|June 28, 2002
Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failureHenry A Glick, Sean M Orzol, Joseph F Tooley, et al.European Heart Journal|January 7, 2011
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trialBertram Pitt, Stefan D Anker, David A Bushinsky, et al.The American Journal of Cardiology|September 29, 2016
Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial)Batric Popovic, Nicolas Girerd, Patrick Rossignol, et al.Journal of the American College of Cardiology|October 23, 2012
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)Orly Vardeny, Dong Hong Wu, Akshay Desai, et al.The American Journal of Cardiology|December 23, 2008
Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial, Ali Ahmed, Finn Waagstein, et al.International Journal of Cardiology|March 27, 2007
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trialAli Ahmed, Bertram Pitt, Shahbudin H Rahimtoola, et al.European Journal of Heart Failure|October 31, 2009
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trialChris Adamopoulos, Ali Ahmed, Renaud Fay, et al.American Journal of Nephrology|September 4, 2017
Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or DiabetesAllan J Collins, Bertram Pitt, Nancy Reaven, et al.European Heart Journal|June 1, 2007
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failureAli Ahmed, Faiez Zannad, Thomas E Love, et al.Pageof 91